gentamicin c1a has been researched along with griseofulvin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athar, M; Jain, VK; Jha, PC; Mehta, V; Modi, K; Panchal, M | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
2 other study(ies) available for gentamicin c1a and griseofulvin
| Article | Year |
|---|---|
Efficiently functionalized oxacalix[4]arenes: Synthesis, characterization and exploration of their biological profile as novel HDAC inhibitors.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Binding Sites; Calixarenes; Cell Line, Tumor; Cell Survival; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary | 2016 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |